Opioid Antagonists in the Treatment of Opioid-Induced Constipation and Pruritus

No abstract is available for this paper.

• Publication year

  2001

• Venue

  The Annals of Pharmacotherapy

• Publication date

  2001-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1345/aph.10121PMID 11197589
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.

  2000cited by this paper
• Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine.

  1998cited by this paper
• Opioid‐sparing Effects of a Low‐dose Infusion of Naloxone in Patient‐administered Morphine Sulfate

  1997cited by this paper
• Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.

  1997cited by this paper
• Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis

  1997cited by this paper
• Opioid‐induced Delay in Gastric Emptying: A Peripheral Mechanism in Humans

  1997cited by this paper
• Safety and Tolerance of Methylnaltrexone in Healthy Humans: A Randomized, Placebo‐Controlled, Intravenous, Ascending‐Dose, Pharmacokinetic Study

  1997cited by this paper
• The Epidemiology of Diabetic Foot Problems

  1996cited by this paper
• Opioid analgesics and antagonists

  1996cited by this paper
• An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer

  1996cited by this paper
• Methods for the assessment of gastric emptying in humans: an overview.

  1996cited by this paper
• Randomised crossover trial of naltrexone in uraemic pruritus.

  1996cited by this paper
• Pathophysiology of itching.

  1996cited by this paper
• Naloxone Versus Nalbuphine Infusion for Prophylaxis of Epidural Morphine-Induced Pruritus

  1996cited by this paper
• Pathophysiology of itching.

  1996cited by this paper
• Randomised trial of oral morphine for chronic non-cancer pain.

  1996cited by this paper
• Methylnaltrexone prevents morphine‐induced delay in oral‐cecal transit time without affecting analgesia: A double‐blind randomized placebo‐controlled trial

  1996cited by this paper
• Pharmacologic treatment of cancer pain.

  1996cited by this paper
• The control of pain in peripheral tissue by opioids.

  1995cited by this paper
• Peripheral opioid receptors.

  1995cited by this paper
• Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes.

  1994cited by this paper
• Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.

  1992cited by this paper
• Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes.

  1992cited by this paper
• A controlled trial of naloxone infusions for the pruritus of chronic cholestasis.

  1992cited by this paper
• Unrecognized constipation in patients with advanced cancer: a recipe for therapeutic disaster.

  1992cited by this paper
• A Controlled Trial of Naloxone Infusions for the Pruritus of Chronic Cholestasis

  1992cited by this paper
• Cancer pain relief and palliative care. Report of a WHO Expert Committee.

  1990cited by this paper
• Role of opiate receptors in the regulation of colonic transit.

  1988cited by this paper
• Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.

  1984cited by this paper
• Intrathecal Administration of Hyperbaric Morphine for the Relief of Pain in Labour

  1984cited by this paper
• Oral morphine in chronic cancer pain

  1984cited by this paper

• Practical Dietary Recommendations of Persian Medicine for Pruritus: A Brief Review

  2024cites this paper
• Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis

  2023cites this paper
• Low dose naloxone for pruritus in systemic sclerosis

  2022cites this paper
• Antagonistas periféricos de los receptores opioides Mu en el tratamiento del estreñimiento inducido por opioides: revisión.

  2020cites this paper
• Naltrexone’s Impact on Cancer Progression and Mortality: A Systematic Review of Studies in Humans, Animal Models, and Cell Cultures

  2020cites this paper
• Cutaneous Sensory Disorders

  2020cites this paper
• The Essentials of Psychodermatology

  2020cites this paper
• Peripheral acting mu opioid receptor antagonists in the treatment of opioid-induced constipation: review

  2020cites this paper
• Acupuncture and Itch: Basic Research Aspects

  2018cites this paper
• Experimental Acupuncturology

  2018cites this paper
• Itch and psyche: psychiatric aspects of pruritus

  2018cites this paper
• A clinical and mechanistic study of topical borneol‐induced analgesia

  2017cites this paper
• Underutilization of Screening Tools for Alcohol Use Disorders Part I: Results from Survey of Practices among North Carolina Mental Health Providers and Brief Review of Available Instruments

  2017cites this paper
• Investigating the analgesic properties of Kurkinorin, a novel mu-opioid receptor analogue of Salvinorin A

  2017cites this paper
• Psychiatric disorders and pruritus.

  2017cites this paper
• Genetic Polymorphisms on OPRM1 Involved in Multiple Responses of a Methadone Maintenance Population: Relationships with Insomnia, Libido, Smoking, and Chemokines

  2016cites this paper
• Itch Management: Systemic Agents.

  2016cites this paper
• Pharmacological interventions for pruritus in adult palliative care patients.

  2016cites this paper
• Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine.

  2016cites this paper
• Managing opioid-induced constipation.

  2015cites this paper
• Methylnaltrexone to Palliate Pruritus in Terminal Hepatic Disease

  2015cites this paper
• Study of the mechanisms of a Japanese traditional fermented medicine in the improvement of constipation

  2015cites this paper
• Opioids, adjuvants, and interventional options for pain management of symptomatic metastases.

  2014cites this paper
• Nalbuphine-induced psychosis treated with naloxone.

  2014cites this paper
• Opioid‐Induced Pruritus

  2013cites this paper
• Understanding itch in systemic sclerosis in order to improve patient quality of life.

  2013cites this paper
• Associations between medication use and functional gastrointestinal disorders: a population‐based study

  2013cites this paper
• Adult Cancer-Related Pain

  2013cites this paper
• The medical treatment of cancer pain

  2013cites this paper
• Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats

  2013cites this paper
• Opioid-Induced Bowel Dysfunction

  2012cites this paper
• [Opioid-induced pruritus].

  2012cites this paper
• Investigation of Natural Product Scaffolds for the Development of Opioid Receptor Ligands

  2012cites this paper
• Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults

  2011cites this paper
• Topical therapies for pruritus.

  2011cites this paper
• Targeted treatment of pruritus: a look into the future

  2011cites this paper
• Narcotic Bowel Syndrome: Under Recognized Diagnosis Resulting in Over-Utilization of Healthcare Resources

  2011cites this paper
• The Synthesis and Pharmacological Evaluation of Salvinorin A Analogues as Opioid Receptor Probes

  2011cites this paper
• Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.

  2010cites this paper
• The Excitotoxin Elimination Diet: A Novel Dietary Intervention for those with Fibromyalgia and Irritable Bowel Syndrome

  2010cites this paper
• Therapy of pruritus

  2010cites this paper
• Adult cancer pain.

  2010cites this paper
• Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain

  2010cites this paper
• Morphine-Sparing Effect by COX-1 Inhibitor Sustains Analgesic Function without Compromising Antigen-Specific Immunity and Antitumor Effect of Naked DNA Vaccine

  2010cites this paper
• Opioid-sparing Effects of Ketorolac and Its Correlation With the Recovery of Postoperative Bowel Function in Colorectal Surgery Patients: A Prospective Randomized Double-blinded Study

  2009cites this paper
• Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats.

  2009cites this paper
• Intravenous naloxone plus transdermal buprenorphine in cancer pain associated with intractable cholestatic pruritus.

  2009cites this paper
• Opioid Bowel Dysfunction and Narcotic Bowel Syndrome: A Population-Based Study

  2009cites this paper
• Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.

  2009cites this paper
• Effectiveness of two opioid antagonists in treating opioid-induced constipation.

  2009cites this paper
• Development of Opioid Transdermal Delivery Systems

  2009cites this paper
• Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching.

  2008cites this paper
• Alvimopan, a peripherally acting mu‐opioid receptor (PAM‐OR) antagonist for the treatment of opioid‐induced bowel dysfunction: Results from a randomized, double‐blind, placebo‐controlled, dose‐finding study in subjects taking opioids for chronic non‐cancer pain

  2008cites this paper
• Putting evidence into practice: evidence-based interventions for the prevention and management of constipation in patients with cancer.

  2008cites this paper
• Co-administration of opioid agonists and antagonists in addiction and pain medicine

  2008cites this paper
• Methylnaltrexone in the treatment of opioid-induced constipation

  2008cites this paper
• Opioid use determines success of videothoracoscopic splanchnicectomy in chronic pancreatic pain patients

  2008cites this paper
• Opioids, an Integrative Part in Perioperative Medicine

  2008cites this paper
• Peripherally acting opioid antagonists in the treatment of opiate-related constipation: a systematic review.

  2007cites this paper
• Alvimopan: a peripheral acting µ-opioid-receptor antagonist used for the treatment of postoperative ileus

  2007cites this paper
• Subcutaneous naloxone for the prevention of intrathecal morphine induced pruritus in elective Caesarean delivery *

  2007cites this paper
• Deletion of μ- and κ-Opioid Receptors in Mice Changes Epidermal Hypertrophy, Density of Peripheral Nerve Endings, and Itch Behavior

  2007cites this paper
• Treatment of pruritus with topically applied opiate receptor antagonist.

  2007cites this paper
• Deletion of mu- and kappa-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior.

  2007cites this paper
• The use of enteral naloxone to treat opioid-induced constipation in a pediatric intensive care unit*

  2006cites this paper
• Managing Opioid-Induced Constipation in Ambulatory-Care Patients

  2006cites this paper
• CHAPTER 18 – Management of Opioid-Related Side Effects

  2006cites this paper
• Histamine as a Potential Initiator of Sickle Pain crisis by Mediation of Sickle Erythrocyte Adherence in a Shear-Dependent Manner

  2006cites this paper
• Rapid Recovery After Major Abdominal Surgery

  2006cites this paper
• Gastrointestinal and colorectal anesthesia

  2006cites this paper
• How best to fight that nasty itch – from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches

  2005cites this paper
• Use of Naloxone for Relief of Constipation

  2005cites this paper
• Changes of Epidermal Mu-Opiate Receptor Expression and Nerve Endings in Chronic Atopic Dermatitis

  2005cites this paper
• Effect of adding ketorolac to intravenous morphine patient‐controlled analgesia on bowel function in colorectal surgery patients – a prospective, randomized, double‐blind study

  2005cites this paper
• Quel est le mode d’utilisation de la naloxone pour traiter la constipation reliée à l’utilisation des opiacés?

  2005cites this paper
• Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial.

  2005cites this paper
• Emerging techniques in the treatment of postoperative pain.

  2004cites this paper
• Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys.

  2004cites this paper
• Alterations of Cajal cell in colon of slow transit constipation mice

  2004cites this paper
• Grundlagen der Symptomkontrolle in der Palliativmedizin

  2004cites this paper
• Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system

  2003cites this paper
• Anticipating and treating opioidassociated adverse effects

  2003cites this paper
• 2002 Medicinal Chemistry Division Award address: monoamine transporters and opioid receptors. Targets for addiction therapy.

  2003cites this paper
• Safety of enteral naloxone and i.v. neostigmine when used to relieve constipation.

  2003cites this paper
• The Future Of Opioid Analgesics

  2003cites this paper
• Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system.

  2003cites this paper
• Treatment of pain in acutely burned children.

  2002cites this paper
• Utilisation de l'antagoniste opioide naltrexone dans la prevention et le controle des effets secondaires causes par les opioides

  2002cites this paper
• Stimulation of peripheral nociceptor endings by low dose morphine and its signaling mechanism.

  2002cites this paper
• Endogenous opiates and behavior: 2001.

  2002cites this paper
• Patient care after discharge from the ambulatory surgical center.

  2001cites this paper
• Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial.

  2001cites this paper
• Incidence, prevalence, and management of opioid bowel dysfunction.

  2001cites this paper
• Alvimopan* (ADL 8-2698) is a novel peripheral opioid antagonist.

  2001cites this paper